Cost-utility analysis of the British Cardiovascular Interventional Society conveyance algorithm for patients with

Guilherme Movio1, Uzma Sajjad1, Rupert Simpson1

  • 1Essex Cardiothoracic Centre, Mid and South Essex NHS Foundation Trust, Basildon, United Kingdom; Anglia Ruskin School of Medicine & MTRC, Chelmsford, United Kingdom.

Resuscitation
|February 20, 2026
PubMed

Insights

Implementing a new cardiac arrest algorithm for out-of-hospital cardiac arrest patients is cost-effective. This strategy improves resource efficiency and shows a high probability of cost-effectiveness at standard willingness-to-pay thresholds.

Area of Science:

  • Cardiology
  • Health Economics
  • Public Health

Background:

  • Out-of-hospital cardiac arrest (OHCA) presents significant mortality and healthcare burdens.
  • The British Cardiovascular Interventional Society's conveyance algorithm directs shockable rhythm patients to specialized Cardiac Arrest Centres for advanced care.
  • This study assessed the economic impact of implementing this algorithm in a large region.

Purpose of the Study:

  • To evaluate the cost-effectiveness of the British Cardiovascular Interventional Society's conveyance algorithm.
  • To compare the algorithm's economic impact against standard care over a lifetime horizon.

Main Methods:

  • A hybrid decision-analytic model (decision tree and Markov model) was employed.
  • Data were sourced from a contemporary observational pilot study.
  • Health outcomes (quality-adjusted life years) and costs were analyzed, with costs discounted at 3.5% annually.

Main Results:

  • The conveyance algorithm demonstrated cost-effectiveness with an incremental cost-effectiveness ratio of £2,926 per quality-adjusted life year gained.
  • Cost savings in intensive care, hospital wards, and ambulance services were observed, slightly offset by increased admission and longer-term care costs.
  • Probabilistic analysis indicated an 86.0% likelihood of cost-effectiveness at a £35,000 per quality-adjusted life year willingness-to-pay threshold.

Conclusions:

  • Selective, rhythm-based transfer to Cardiac Arrest Centres enhances resource efficiency with minimal added cost.
  • While clinical outcomes require further investigation due to observational data limitations, the economic evaluation supports broader clinical and health system benefit studies.
  • Further prospective, multi-centre research is recommended to validate these findings.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...